Clincosm LogoSign in Get a demo

Pancreatic Neoplasms

Showing 1 - 25 of 247
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Through Detection of Elastase-1 Combined With Other Examinations

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +5 more
  • Pancreatic elastase-1 in blood serum
  • Jinan, Shandong, China
    Ning Zhong
Sep 10, 2023

Pancreatic Tumors Trial in Shanghai (Sofantinib?abraxane?gemcitabine, Abraxane combined with gemcitabine)

Not yet recruiting
  • Pancreatic Neoplasms
  • Shanghai, China
    Fudan University ShangHai Cancer Center
Jul 31, 2023

Tumors, Prostatic Tumors, Castration-Resistant, Stomach Tumors Trial in United Kingdom (HTL0039732 Capsules, HTL0039732 Capsules

Recruiting
  • Neoplasms
  • +13 more
  • HTL0039732 Capsules
  • HTL0039732 Capsules and atezolizumab infusion
  • Cambridge, United Kingdom
  • +4 more
Jul 5, 2023

Determining Individualized Cancer Therapy in Pancreatic Cancer

Not yet recruiting
  • Pancreatic Neoplasms
  • Targeted Therapy
  • Milwaukee, Wisconsin
    Froedtert Hospital and the Medical College of Wisconsin
Jun 14, 2023

Pancreatic Tumors Trial in Beijing, Nanjing, Shanghai (QingyiHuaji optimized formula)

Recruiting
  • Pancreatic Neoplasms
  • QingyiHuaji optimized formula
  • Beijing, Beijing, China
  • +3 more
Apr 22, 2023

Pancreatic Tumors Trial in Shanghai (Utidelone injection in combination with gemcitabine)

Recruiting
  • Pancreatic Neoplasms
  • Utidelone injection in combination with gemcitabine
  • Shanghai, Shanghai, China
    Shanghai First People's Hospital
Mar 21, 2023

Model for Pancreatic Cystic Tumors Based on Pancreatic Cystic

Recruiting
  • Pancreatic Neoplasms
  • +2 more
  • cfDNA methylation sequencing and proteome analysis
  • Shanghai, Shanghai, China
    Changhai Hospital
Feb 17, 2023

Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +15 more
  • A2B530
  • xT-Onco with HLA-LOH Assay
  • Duarte, California
  • +6 more
Feb 10, 2023

Pancreatic Tumors Trial in Majadahonda (Trimodal prehabilitation)

Recruiting
  • Pancreatic Neoplasms
  • Trimodal prehabilitation
  • Majadahonda, Madrid, Spain
    Hospital Universitario Puerta de Hierro Majadahonda
Jan 31, 2023

FGF19 in Obstructive Cholestasis: "Unveil the Signal"

Recruiting
  • Cholestasis
  • +4 more
  • Biospecimen sampling
  • Aachen, Germany
    RWTH Aachen
Feb 6, 2023

Individuals With New-Onset Diabetes Mellitus

Recruiting
  • Pancreatic Cancer
  • Pancreatic Neoplasms
  • MRI/MRCP
  • New Haven, Connecticut
  • +1 more
Jan 19, 2023

Cutaneous Melanoma, NSCLC, Colorectal Tumors Trial in Denver (SGN-BB228)

Recruiting
  • Cutaneous Melanoma
  • +4 more
  • Denver, Colorado
    Sarah Cannon Research Institute at HealthONE - Denver
Jan 17, 2023

Pancreatic Tumors Trial (Tislelizumab)

Not yet recruiting
  • Pancreatic Neoplasms
  • (no location specified)
Dec 26, 2022

Chromogranin A as Blood Marker in Cancer Patients

Completed
  • Gastric Neoplasms
  • +3 more
  • BRAHMS CgA II KRYPTOR
  • Palo Alto, California
  • +3 more
Dec 19, 2022

Pancreas Cancer, Exosomes, Extracellular Vesicles Trial

Not yet recruiting
  • Pancreas Cancer
  • +3 more
    • (no location specified)
    Dec 6, 2022

    Hepatic Tumors, Biliary Tract Tumors, Pancreatic Tumors Trial in Seoul (Perioperative rehabilitation program, Conventional)

    Completed
    • Hepatic Neoplasms
    • +2 more
    • Perioperative rehabilitation program
    • Conventional
    • Seoul, Korea, Republic of
      Asan Medical Center, University of Ulsan College of Medicine
    Nov 16, 2022

    Composite Outcome Measure in Laparoscopic

    Completed
    • Pancreatic Neoplasms
    • No intervention
    • Wuhan, Hubei, China
      Department of Biliary and Pancreatic Surgery, Tongji Hospital, A
    Nov 8, 2022

    Pancreatic and Periampullary Tumors in Greenland Inuit

    Completed
    • Pancreatic Neoplasms
    • Periampullary Neoplasms
    • outcome
    • (no location specified)
    Oct 26, 2022

    The Canadian/US Integrative Oncology Study

    Active, not recruiting
    • Breast Neoplasms
    • +3 more
      • Scottsdale, Arizona
      • +11 more
      Oct 21, 2022

      Landscape and Survival in Metastatic Pancreatic Cancer After

      Recruiting
      • Pancreatic Neoplasms
        • Seoul, Korea, Republic of
          Yonsei University Health System, Severance Hospital
        Oct 19, 2022

        Tumor, Stomach, Gastric Tumors Malignant, Pancreatic Tumors Trial in Bogotá (Petiveria Alliacea Preparation, Placebo)

        Not yet recruiting
        • Neoplasm, Stomach
        • +8 more
        • Petiveria Alliacea Preparation
        • Placebo
        • Bogotá, Colombia
          Pontificia Universidad Javeriana
        Oct 16, 2022

        Pancreatic Tumors Trial (The medical device used in this study is a 980 nm wavelength diode laser with maximum output of 30 W

        Not yet recruiting
        • Pancreatic Neoplasms
        • The medical device used in this study is a 980 nm wavelength diode laser with maximum output of 30 W (EUFOTON Laser Spectrum).
        • (no location specified)
        Oct 16, 2022

        Hereditary High Risk Individuals

        Recruiting
        • Pancreatic Neoplasms
        • MRI/MRCP
        • Norwalk, Connecticut
          Western Connecticut Health Network
        Oct 10, 2022

        Feasibility of Using Ultrasound to Track Respiration Motion

        Completed
        • Pancreatic Neoplasms
        • Ultrasound
        • Milwaukee, Wisconsin
          Froedtert Hospital & the Medical College of Wisconsin
        Oct 7, 2022

        Pancreas Cancer Trial (surufatinib + camrelizumab + nab-paclitaxel + S-1, nab-paclitaxel + gemcitabine)

        Recruiting
        • Pancreatic Cancer
        • +3 more
        • surufatinib + camrelizumab + nab-paclitaxel + S-1
        • nab-paclitaxel + gemcitabine
        • Beijing, China
          Chinese PLA General Hospital
        Sep 26, 2022